首页> 外文OA文献 >Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers
【2h】

Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers

机译:基于可生物降解聚合物的蛋白质缓释纳米粒的制备,表征和体外评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Controlled drug delivery technology of proteins/peptides from biodegradable nanoparticles has emerged as one of the eminent areas to overcome formulation associated problems of the macromolecules. The purpose of the present investigation was to develop protein-loaded nanoparticles using biodegradable polymer poly l-lactide-co-glycolidic acid (PLGA) with bovine serum albumin (BSA) as a model protein. Despite many studies available with PLGA-based protein-loaded nanoparticles, production know-how, process parameters, protein loading, duration of protein release, narrowing polydispersity of particles have not been investigated enough to scale up manufacturing of protein-loaded nanoparticles in formulations. Different process parameters such as protein/polymer ratio, homogenizing speed during emulsifications, particle surface morphology and surface charges, particle size analysis and in-vitro protein release were investigated. The in-vitro protein release study suggests that release profile of BSA from nanoparticles could be modulated by changing protein-polymer ratios and/or by varying homogenizing speed during multiple-emulsion preparation technique. The formulation prepared with protein-polymer ratio of 1:60 at 17,500 rpm gave maximum protein-loading, minimum polydispersion with maximally sustained protein release pattern, among the prepared formulations. Decreased (10,000 rpm) or enhanced (24,000 rpm) homogenizing speeds resulted in increased polydispersion with larger particles having no better protein-loading and -release profiles in the present study.
机译:来自生物可降解纳米粒子的蛋白质/肽的受控药物递送技术已经成为克服大分子与制剂相关的问题的重要领域之一。本研究的目的是使用可生物降解的聚合物聚l-丙交酯-共-乙醇酸(PLGA)和牛血清白蛋白(BSA)作为模型蛋白来开发负载蛋白质的纳米颗粒。尽管基于PLGA的载有蛋白质的纳米颗粒有许多研究,但生产技术,工艺参数,蛋白质载量,蛋白质释放的持续时间,变窄的颗粒多分散性尚未得到足够的研究,以扩大制剂中载有蛋白质的纳米颗粒的生产规模。研究了不同的工艺参数,如蛋白质/聚合物比,乳化过程中的均化速度,颗粒表面形态和表面电荷,粒度分析和体外蛋白质释放。体外蛋白质释放研究表明,可以通过改变蛋白质与聚合物的比例和/或在多乳液制备技术中改变均质速度来调节BSA从纳米粒子的释放曲线。在所制备的制剂中,以17:500 rpm的蛋白质-聚合物比率为1:60制备的制剂在最大的蛋白质负载量,最小的多分散性以及最大程度的持续蛋白质释放模式下获得了最大的负载。降低(10,000 rpm)或提高(24,000 rpm)的均质速度会导致多分散性增加,而较大的颗粒在本研究中没有更好的蛋白质负载和释放曲线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号